This bill reauthorizes funding for the State Offices of Rural Health Program, which supports state-level efforts to improve healthcare access in rural areas. It authorizes $12.5 million annually for fiscal years 2023 through 2027 and increases funding to $13.5 million per year for fiscal years 2028 through 2032. The money will be distributed through grants to states that operate offices focused on rural health initiatives. This legislation directly affects state health departments and organizations working to address healthcare disparities in rural communities. The bill makes no changes to eligibility requirements or program goals, only extending and adjusting the funding levels.
HR 1785, the Preventing Medicare Telefraud Act, requires doctors to have seen Medicare patients in person at least once within the past six months before ordering high-cost durable medical equipment or laboratory tests via telehealth. This applies to services covered under Medicare, directly affecting providers who frequently use telehealth for these specific high-cost items. The bill mandates Medicare contractors to audit providers ordering 90% or more of such equipment or tests via telehealth, and also requires providers to submit their National Provider Identifier (NPI) when billing for telehealth services. These provisions aim to prevent potential fraud by ensuring in-person evaluations precede telehealth orders for expensive medical items.
S 380, the Rural Obstetrics Readiness Act, creates a federal program to improve emergency obstetric care in rural health facilities without dedicated obstetric units. It establishes evidence-based training for non-obstetric providers to handle childbirth emergencies (like hemorrhage or severe hypertension), funds equipment purchases, and launches a telehealth pilot for rapid specialist consultations. The bill authorizes $5 million for training (2026-2028), $15 million for equipment and workforce support (2026-2029), and $5 million for teleconsultation (2026-2029). It directly affects rural hospitals and clinics in maternity care shortage areas, requiring them to coordinate with maternal health programs and develop emergency protocols. A separate study will map maternity ward closures and regional care patterns, reporting to Congress within three years.
S 3395, the Mammography Access for Veterans Act of 2025, permanently expands telehealth mammography services for veterans by ending the previous pilot program restrictions. It requires the Department of Veterans Affairs to provide at least one mammography option - full-service, tele-screening, or mobile - in every state and Puerto Rico within two years. All programs must comply with accessibility standards for veterans with paralysis, spinal cord injuries, or other disabilities. This directly affects veterans needing breast cancer screenings, particularly those in rural areas or with mobility challenges.
Sustainable Cardiopulmonary Rehabilitation Services in the Home Act This bill permanently allows services relating to cardiac rehabilitation programs, intensive cardiac rehabilitation programs, and pulmonary rehabilitation programs to be furnished via telehealth at a beneficiary's home under Medicare.
This bill requires the FDA to reinstate the 2011 safety program for mifepristone (the drug sold as Mifeprex) and bans its importation into the U.S. It creates federal liability for harm caused by illegal importers of the drug, allowing lawsuits for bodily injury or mental health harm resulting from unauthorized importation. The law applies specifically to telehealth providers, pharmacies, or others who knowingly import mifepristone across state lines. It takes effect 90 days after enactment.
The Women's Health Protection Act of 2025 would protect access to abortion services across the United States by prohibiting states from imposing restrictions that are more burdensome than those on comparable medical procedures. The bill directly affects people seeking abortion care and health care providers by banning restrictions such as mandatory in-person visits, requirements for specific tests, limitations on telemedicine, and rules based on a patient's reason for seeking abortion. It prohibits state laws that single out abortion for unnecessary restrictions while allowing post-viability abortions when necessary to protect a patient's life or health. The bill preempts conflicting state laws and provides enforcement mechanisms through private lawsuits and actions by the Attorney General.
HR 5357, the College Students Continuation of Mental Health Care Act of 2025, allows college mental health providers to offer telehealth services to enrolled or recently attending students across state lines. It directly affects college mental health providers (employed by institutions of higher education) and students registered at or who attended the college within the past three months. Key provisions require providers to verify student identity, obtain consent for telehealth, maintain backup communication methods, and respect state prohibitions on specific services while operating under their home state’s licensing rules. The bill also clarifies that malpractice insurance covers these telehealth services as if provided in the provider’s home state and permits states to form compacts to facilitate cross-state telehealth.
The NIH Clinical Trial Integrity Act requires sponsors of clinical trials approved by the National Institutes of Health (NIH) to set and meet specific goals for including participants from diverse racial, ethnic, age, and sex groups. This includes submitting detailed plans for recruitment and retention - such as using telemedicine for follow-ups or flexible scheduling - and reporting annual demographic data without personally identifiable information. Trials failing to meet these goals must develop a community-informed strategic plan to improve participation, which the NIH will publish. The bill also mandates a national awareness campaign to promote diverse trial participation and a study on reducing cost barriers for participants.
This bill extends the temporary waiver allowing hospitals to provide acute care at home until 2030, directly affecting hospitals participating in the Acute Hospital Care at Home initiative and the patients receiving care through this program. It requires the Department of Health and Human Services to conduct a detailed study by September 2028, comparing care quality, costs, patient outcomes, and experiences between home-based care and traditional inpatient hospital care. The study must analyze specific metrics like readmission rates, staffing ratios, treatment types, and patient demographics across participating and non-participating hospitals. The findings will be reported to Congress, providing data to inform future policy decisions about home-based hospital care.
